Planta Med 2004; 70(3): 266-268
DOI: 10.1055/s-2004-818921
Letter
© Georg Thieme Verlag Stuttgart · New York

Bisbenzyltetrahydroisoquinolines, a New Class of Inhibitors of the Mitochondrial Respiratory Chain Complex I

Susana Granell1 , Inmaculada Andreu1 , Daniel Martí2 , Adrién Cavé3 , Raúl Aragón4 , Ernesto Estornell2 , Diego Cortes1 , M. Carmen Zafra-Polo1
  • 1Departamento de Farmacología, Laboratorio de Farmacognosia, Universidad de Valencia, Burjassot, Valencia, Spain
  • 2Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Valencia, Burjassot, Valencia, Spain
  • 3Centre de Biochimie Structurale, Faculté de Pharmacie, Montpellier, France
  • 4Departamento de Química, Universidad del Valle, Cali, Colombia
This research was supported by the Spanish Dirección General de Investigación under grant SAF 2001-3142. We also wish to thank the Secretaría del Plan Valenciano de Investigación Científica, Desarrollo Tecnológico e Innovación de la Generalitat Valenciana under grant GV01-282
Further Information

Publication History

Received: August 5, 2003

Accepted: January 10, 2004

Publication Date:
23 March 2004 (online)

Preview

Abstract

Four bisbenzyltetrahydroisoquinoline alkaloids (-)-medelline, (+)-antioquine, (+)-aromoline, and (+)-obamegine were isolated from the fruits of Xylopia columbiana. These compounds, the previously isolated alkaloids (+)-thaligrisine and (+)-isotetrandrine, as well as their O-acetylated derivatives were assayed on submitochondrial particles from beef heart as inhibitors of the mammalian respiratory chain. The results revealed that these alkaloids act as selective inhibitors of mitochondrial complex I in a 0.15 - 4.71 μM range. O-Acetylation, which increases their lipophilicity, considerably increased the inhibitory potency.

References

Prof. Dr. Diego Cortes

Departamento de Farmacología

Facultad de Farmacia

Avda. Vicent Andrés Estellés s/n

46100 Burjassot

Valencia

Spain

Phone: +34-96-354-4975

Fax: +34-96-354.4943

Email: dcortes@uv.es